Skyrizi 150 mg solution for injection in pre-filled pen

Company
AbbVie Limited
Active Ingredient
Strength
  • Risankizumab: 150 mg
Dosage Form
Solution for injection in pre- filled pen
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
SPC section shown.

Loading the document

AbbVie Limited

Citywest Business Campus, Dublin 24, Ireland